AREXVY
STN: 125775
Proper Name: Respiratory Syncytial Virus Vaccine, Adjuvanted
Tradename: AREXVY
Manufacturer: GlaxoSmithKline Biologicals SA
Indication:
- For active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in individuals 60 years of age and older.
Product Information
Supporting Documents